Morgan Stanley Finance LLC filed a Free Writing Prospectus to Preliminary Pricing Supplement No. 19,768 on November 2, 2026, summarizing the terms of SX5E Market-Linked Notes due November 28, 2031.
Morgan Stanley Finance LLC filed a Free Writing Prospectus to Preliminary Pricing Supplement No. 19,731 on November 2, 2026, covering Worst-of NDXT and RTY Contingent Income Auto-Callable Securities due March 3, 2028.
Morgan Stanley Finance LLC filed a Free Writing Prospectus to Preliminary Pricing Supplement No. 19,880 on November 2, 2026, describing NDX Jump Securities with an Auto-Callable Feature due November 29, 2029, issued under Registration Statement Nos. 333-293641 and 333-293641-01.
Morgan Stanley Finance LLC filed a Free Writing Prospectus to Preliminary Pricing Supplement No. 19,881 on November 2, 2026, disclosing terms for NDX Jump Securities with an Auto-Callable Feature due December 5, 2029.
Steven Fambro, an officer and director of Aptera Motors Corp, filed a Form 144 notice on November 2, 2026, disclosing a proposed sale of 6,245 Class B shares through Fidelity Brokerage Services LLC on NASDAQ.
Erie Indemnity Company Executive Vice President Sarah Shine filed a Form 4 on November 2, 2026, reporting a participant-directed transaction under the company's 401(k) Plan dated October 31, 2026.
UFP Industries Inc Executive Chairman Matthew J. Missad filed a Form 4 on November 2, 2026, reporting the acquisition of 17 phantom stock units on October 30, 2026, under the company's Deferred Compensation Plan.
Veralto Corp officer Bernard M. Skeete filed a Form 144 notice on November 2, 2026, proposing the sale of 1,514 shares of common stock acquired through a stock option exercise on the same date.
Douglas Edward Smith, Executive Vice President at Erie Indemnity Co, filed a Form 4 on November 2, 2026, reporting a participant-directed 401(k) plan transaction dated October 31, 2026.
Lazard, Inc. filed an 8-K press release on November 2, 2026, announcing the completion of its acquisition of Campbell Lutyens and the simultaneous launch of Lazard CL, a new private capital advisory business listed under NYSE:LAZ.